Medicines

This information is intended for Australian and New Zealand residents only.

Medicines

We operate or partner to make our medicines available in nearly 75 countries. To report an adverse event or a product complaint, or to request information about our products, please visit our Adverse Events or Medical Enquiries pages.

Australia

Oncology Therapeutic Area

  • Defitelio® (defibrotide sodium)

    PI CMI
  • Vyxeos® (daunorubicin and cytarabine)

    PICMI
  • ENRYLAZE (RECOMBINANT CRISANTASPASE)

    PICMI

Neuroscience Therapeutic Area

  • Sativex® (nabiximols)

    PICMI
  • Epidyolex® (cannabidiol)

    PICMI